Comparison of tacalcitol ointment with short-contact dithranol therapy in the treatment of psoriasis vulgaris: a randomized multicentre, open prospective study on efficacy and safety

References

• Galewsky E. Über Cignolin ein Ersatzpräparat des Chrysarobins. Dermatol Wochnschr 1916; 62: 113–15
   Google Scholar
• Ashton R E. Anthralinhistorical and current perspectives. J Am Acad Dermatol 1983; 9: 173
   PubMed Web of Science ®Google Scholar
• Ingram J T. The approach to psoriasis. BMJ 1953; 2: 591–4
   PubMed Web of Science ®Google Scholar
• van de Kerkhof P CM. Dithranol treatment for psoriasis: after 75 years, still going strong!. Eur J Dermatol 1991; 1: 79–88
   Google Scholar
• Young E. Treatment of psoriasis with dithranol cream compared with dithranol paste. Dermatologica 1986; 173: 285–7
   Google Scholar
• Ryatt K S, Statham B N, Rowell N R. Short-contact modification of the Ingram regime. Br J Dermatol 1984; 111: 455–9
   Google Scholar
• Grattan C EH, Hallam F, Whitefield M. A new aqueous dithranol gel for psoriasis: comparison with placebo and calcipotriol ointment. J DermatolTreat 1997; 8: 11–15
   Google Scholar
• van de Kerkhof P CM, Snater E, Verbeek-Gijsbers W, et al. Intensified outpatient short-contact treatment with dithranol. J Dermatol Treat 1997; 8: 64–7
   Google Scholar
• Schaefer H, Farber E M, Goldberg L, Schalla W. Limited application period for dithranol in psoriasis. Br J Dermatol 1980; 102: 571–3
   PubMed Web of Science ®Google Scholar
• Runne U, Kunze J. Short-duration (‘minutes’) therapy with dithranol for psoriasis: a new outpatient regimen. Br J Dermatol 1982; 106: 135–40
   PubMed Web of Science ®Google Scholar
• Fuchs J, Zimmer G, Wöbling R H, Milbrandt R. On the interaction between anthralin and mitochondria: a revision. Arch Dermatol Res 1986; 279: 59–65
   Google Scholar
• Reed C I, Struck H C, Steck I E. Other therapeutic applications of vitamin D. Vitamin D chemistry, physiology, pharmacology, pathology, experimental and clinical investigations, C I Reed, H C Struck, I E Steck. The University of Chicago, Chicago 1939; 312–13
   Google Scholar
• Morimoto S. A patient with psoriasis cured by 1-hydroxyvitamin D3. Med J Osaka Univ 1985; 35: 51–4
   PubMedGoogle Scholar
• Kato T. Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1,24-dihydroxy-cholecalciferol. Br J Dermatol 1986; 115: 431–3
   PubMed Web of Science ®Google Scholar
• Kragballe K. D3 analogue (MC 903) in a double-blind study. Br J Dermatol 1988; 119: 223–30
   PubMed Web of Science ®Google Scholar
• van de Kerkhof P CM, Werfel T, Haustein U F, et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996; 135: 758–65
   PubMed Web of Science ®Google Scholar
• Kimura H, Nishiyama S, Nakamizo Y. Study on the efficacy of TV-02 ointment on psoriasis. West jpn Dermatol 1989; 51: 970–9
   Google Scholar
• Nishimura M, Hori Y, Nishiyama S, Nakowizo Y. Topical 1α,24 (R) dihydroxyvitamin D3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 1993; 3: 255–61
   Google Scholar
• Scarpa C. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J Eur Acad Dermatol Venereol 1996; 6: 142–6
   Google Scholar
• Kimura H, Nishiyama S, Nakamizo Y, et al. Investigation of the usefulness of TV-02 ointment for patients with psoriasis—right and left comparison test with betamethasone valerate ointment. West Jpn Dermatol 1989; 51: 963–9
   Google Scholar
• Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica 1978; 157: 238–44
   PubMedGoogle Scholar
• Wei L J, Lachin J M. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 1984; 79: 653–61
   Web of Science ®Google Scholar
• Lachin J M. Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. Stat Med 1992; 11: 1151–70
   PubMed Web of Science ®Google Scholar
• Colditz G A, Miller J N, Mosteller F. Measuring gain in the evaluation of medical technology: the probability of a better outcome. Int J Technol Assess Health Care 1988; 4: 637–42
   Google Scholar
• Hauck W W, Anderson S. A proposal for interpreting and reporting negative studies. Stat Med 1986; 5: 203–9
   PubMed Web of Science ®Google Scholar
• Paramsothy Y, Lawrence C M. Time course and intensity of anthralin inflammation on involved and uninvolved psoriatic skin. Br J Dermatol 1987; 116: 517–19
   PubMed Web of Science ®Google Scholar
• Lawrence C M. Topical dithranol (anthralin). J Dermatol Treat 1997; 8: 31–2
   Google Scholar
• Berth-Jones J, Chu A C, Dodd W AH, et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266–71
   PubMed Web of Science ®Google Scholar
• Berth-Jones J. Topical vitamin D analogues. J Dermatol Treat 1997; 8: 32–5
   Google Scholar
• van de Kerkhof P CM, van de Vleuten C JM, Gerritsen M JP, et al. Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment. Eur J Dermatol 1997; 7: 421–5
   Web of Science ®Google Scholar
• Farkas B. Comparison of tacalcitol with dithranol. Dermatol Newsletter 1996; 4: 1
   Google Scholar
• Eto M, Nishiyama S, Nakamizo Y, et al. Study on the efficacy of TV-02 ointment for psoriasis—results of a double-blind study of left and right sides with a placebo (ointment base) as a control. Nishinihon J Dermatol 1991; 53: 1252–61
   Google Scholar
• Baadsgaard O, Traulsen J, Roed-Petersen J, Jakobsen H B. Optimal concentration of tacalcitol in once-daily treatment of psoriasis. J Dermatol Treat 1995; 6: 145–50
   Web of Science ®Google Scholar
• Bettinger J, Gloor M, Fluhr J, Gehring W. Therapeutischer Nutzen von Tacalcitol bei der Psoriasis vulgaris unter besonderer Berücksichtigung der okklusiven Applikation. Z Hautkr 1996; 71: 28–32
   Google Scholar
• Greaves M W. Topical corticosteroids. J Dermatol Treat 1997; 8: 35–6
   Google Scholar
• Wilkinson J M. Hypersensitivity to topical corticosteroids. Clin Exp Dermatol 1994; 19: 1–11
   PubMed Web of Science ®Google Scholar
• Farkas B, Bonnekoh B, Mahrle G. Repeated treatment with dithranol induces a tolerance reaction in keratinocytes in vitro. Arch Dermatol Res 1991; 283: 337–41
   Google Scholar
• MacKie R M. Topical coal tar. J Dermatol Treat 1997; 8: 30–1
   Google Scholar